Change in Leadership of SomnoMed
Filed with ASX · · 1 page · English
Earlier from Somnomed
- Response to Appendix 4C Query
- Strong first quarter in Core business diluted by RSS results
- Full year results and the consolidation of RSS operations
- SomnoMed posts 30% revenue growth for FY2018
- Trading Update
Later from Somnomed
- 2018 AGM addresses - Chairman and CEO
- Core revenue growth up 13% in Q2
- S&P DJI Announces March 2019 Quarterly Rebalance
- Core revenue growth up 9% in Q3
- 500,000 patients treated worldwide
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed